ARCHIVES

M.D. Anderson Must Evaluate 8 Patients In Controversial Study

This article is from The Cancer Letter archive.

Vol. 22 No. 22 | May 31, 1996

Download PDF Visit The Full Archive

Related Articles

In Brief: Goldsmith Named CEO of CancerCare

April 11, 2014

ASCO: NCI Authorities Still Important

June 11, 2010

Parkinson Heads Oncology At Amgen

May 2, 2003

NIH Orders Duke Medical Center To Stop Enrollment In Human Research Studies

May 14, 1999

Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.

June 2, 2000

Panel Debates Whether DCIS Needs A New Name

September 25, 2009